Can GLP-1 medications cause NAION, sometimes called an “eye stroke”? As a nurse practitioner, I’m breaking down what we actually know about GLP-1s, semaglutide, tirzepatide, NAION, and the risk of permanent vision loss.
There has been growing concern about a possible connection between GLP-1 medications and non-arteritic anterior ischemic optic neuropathy (NAION). But how common is it? Is the risk the same for everyone? And what does the research actually show?
In this video, I look at the evidence surrounding Ozempic, Wegovy, Mounjaro, Zepbound and other GLP-1 medications, including what we know about NAION, diabetes, obesity, and semaglutide.

Medical Disclaimer: This channel is for information and education purposes only. Though I am a nurse practitioner, I am not your healthcare provider. Interacting with this channel does not constitute a provider-patient relationship. All medications, including GLP-1 medications, can cause serious side-effects. Always contact your licensed healthcare provider for any decisions regarding GLP-1 or other medications and for all of your healthcare decisions.

Affiliate Disclosure: As an Amazon Associate, I earn from qualifying purchases.
Products I  Use and Recommend:

🔹 Needle Clipper — inexpensive, small, & safe disposal for 100s of needles
https://amzn.to/45w86YV

🔹 Digital Food Scale — Perfect for measuring portions!
https://amzn.to/4flTgbx

#GLP1 #Tirzepatide #WeightLossJourney #NPOnAGLP #GLP1Community #ObesityMedicine